Medicare Enrolled

Dr. Jeffrey Feldman, MD

Nephrology · Union, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
440 CHESTNUT ST, Union, NJ 07083
9086869330
In practice since 2006 (20 years)
NPI: 1124081336 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Feldman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Feldman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Feldman

Dr. Jeffrey Feldman is a nephrology specialist in Union, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Feldman performed 1,085 Medicare services across 384 unique beneficiaries.

Between the years covered by Open Payments, Dr. Feldman received a total of $299,518 from 57 pharmaceutical and/or device companies across 1330 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Feldman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 1,085 Medicare services $299,518 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,085
Medicare services
Bottom 35% in NJ for nephrology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
384
Unique beneficiaries
$112
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~54 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
459 $139 $487
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
213 $104 $343
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
187 $99 $363
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
88 $67 $240
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
64 $13 $72
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
34 $111 $449
New patient office visit, complex (60-74 min) 24 $178 $691
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
16 $145 $551
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$299,518
Total received (2018-2024)
Avg $42,788/year across 7 years
Top 1% in NJ for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
1,330
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$278,051 (92.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,411 (4.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,055 (2.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$94,616
2023
$34,440
2022
$107,090
2021
$31,429
2020
$11,818
2019
$16,798
2018
$3,326

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bayer Healthcare Pharmaceuticals Inc.
$37,963
Lilly USA, LLC
$32,021
Boehringer Ingelheim Pharmaceuticals, Inc.
$15,312
AstraZeneca Pharmaceuticals LP
$5,809
Novartis Pharmaceuticals Corporation
$1,255
Amgen Inc.
$388
Novo Nordisk Inc
$263
Janssen Scientific Affairs, LLC
$222
Lexicon Pharmaceuticals, Inc.
$197
Medtronic, Inc.
$153
CALLIDITAS THERAPEUTICS US INC.
$147
Corcept Therapeutics
$125
Abbott Laboratories
$111
Ardelyx, Inc.
$79
Vifor Pharma, Inc.
$79
Regeneron Pharmaceuticals, Inc.
$75
OPKO Pharmaceuticals, LLC
$72
AKEBIA THERAPEUTICS INC
$56
Merck Sharp & Dohme LLC
$55
Fresenius USA Marketing, Inc.
$51
GlaxoSmithKline, LLC.
$48
Janssen Pharmaceuticals, Inc
$34
Otsuka America Pharmaceutical, Inc.
$29
Dexcom, Inc.
$21
Travere Therapeutics, Inc.
$19
SCPHARMACEUTICALS INC.
$16
Esperion Therapeutics, Inc.
$15
Top 3 companies account for 90.1% of 2024 payments
All-time payments by company (2018-2024) ›
Bayer HealthCare Pharmaceuticals Inc.
$119,578
Bayer Healthcare Pharmaceuticals Inc.
$46,225
Lilly USA, LLC
$36,049
Boehringer Ingelheim Pharmaceuticals, Inc.
$31,011
AstraZeneca Pharmaceuticals LP
$26,955
Janssen Pharmaceuticals, Inc
$16,186
GlaxoSmithKline, LLC.
$8,159
Amgen Inc.
$4,467
Novo Nordisk Inc
$2,156
Novartis Pharmaceuticals Corporation
$1,354
Janssen Scientific Affairs, LLC
$1,102
OPKO Pharmaceuticals, LLC
$858
SANOFI-AVENTIS U.S. LLC
$542
ARBOR PHARMACEUTICALS, INC.
$443
Vifor Pharma, Inc.
$411
Esperion Therapeutics, Inc.
$410
Merck Sharp & Dohme Corporation
$307
Amarin Pharma Inc.
$305
Regeneron Pharmaceuticals, Inc.
$295
Merck Sharp & Dohme LLC
$227
Lexicon Pharmaceuticals, Inc.
$197
Corcept Therapeutics
$174
Abbott Laboratories
$165
Fresenius USA Marketing, Inc.
$160
CALLIDITAS THERAPEUTICS US INC.
$159
Medtronic, Inc.
$153
Dexcom, Inc.
$141
Otsuka America Pharmaceutical, Inc.
$138
AKEBIA THERAPEUTICS INC
$132
Horizon Therapeutics plc
$125
Ardelyx, Inc.
$109
Relypsa, Inc.
$103
Daiichi Sankyo Inc.
$81
Alexion Pharmaceuticals, Inc.
$47
Mallinckrodt LLC
$45
Azurity Pharmaceuticals, Inc.
$44
Allergan Inc.
$40
Mallinckrodt Hospital Products Inc.
$39
Sanofi Pasteur Inc.
$38
DEXCOM, INC.
$35
Insulet Corporation
$33
Calliditas Therapeutics US Inc.
$29
Xeris Pharmaceuticals, Inc.
$29
Eisai Inc.
$28
Mallinckrodt Enterprises LLC
$27
Aurinia Pharma U.S., Inc.
$27
Kowa Pharmaceuticals America, Inc.
$24
Travere Therapeutics, Inc.
$19
SANOFI PASTEUR INC.
$18
ANI Pharmaceuticals, Inc.
$18
Exeltis, USA Inc.
$17
Nestle HealthCare Nutrition Inc.
$17
SCPHARMACEUTICALS INC.
$16
AbbVie Inc.
$14
Regeneron Healthcare Solutions, Inc.
$13
PFIZER INC.
$12
Noden Pharma USA Inc
$11
Top 3 companies account for 67.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Aimovig · Auryxia · BENLYSTA · BRILINTA · BYSTOLIC · Belviq · CARDIOMEMS · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ELIQUIS · ENTRESTO · EVKEEZA · Edarbi · Edarbyclor · FARXIGA · FREESTYLE LIBRE · FUROSCIX · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · Horizant · IBSRELA · INJECTAFER · INVOKANA · JANUMET XR · JANUVIA · JARDIANCE · JESDUVROQ · JYNARQUE · KRYSTEXXA · Kanuma · Kerendia · Korlym · LEQVIO · LINZESS · LOKELMA · LUPKYNIS · Levemir · Livalo · MENACTRA · MOUNJARO · NEXLETOL · NEXLIZET · Omnipod · Otezla · Ozempic · PRALUENT · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · RYBELSUS · Rayaldee · Repatha · Rybelsus · SEGLUROMET · SOLIQUA 100/33 · STEGLATRO · SYMPLICITY G3 · Saxenda · Strensiq · TARPEYO · TEKTURNA · TOUJEO · TRULICITY · Tavneos · Tresiba · Ultomiris · VERQUVO · VIBERZI · Vascepa · Velphoro · Veltassa · Victoza · Wegovy · XARELTO · Xultophy 100/3.6 · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in nephrology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for nephrology in NJ.

Looking for a nephrology specialist in Union?
Compare nephrologists in the Union area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists within 10 mi
634
Per 100K population
110.7
County median income
$100,117
Nearest hospital
NEWARK BETH ISRAEL MEDICAL CENTER
3.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Feldman is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of NJ peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Feldman experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Feldman performed 459 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Feldman receive payments from pharmaceutical companies?
Yes. Dr. Feldman received a total of $299,518 from 57 companies across 1,330 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Feldman's costs compare to other nephrologists in Union?
Dr. Feldman's average Medicare payment per service is $112. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Feldman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →